Jared Kaltwasser

New research suggests hyperactivity in patients’ brain networks—known as explosive synchronization—leads to chronic pain in fibromyalgia.

Samples of the female genital tracts of women infected with HIV show that the virus loses much of its genetic diversity by the time it hits the bloodstream.

A first-of-its-kind study suggests teens and young adults become persistent users of opioid painkillers at rates similar to their older peers.

A new meta-analysis suggests ART therapy has a positive impact on HPV and cervical cancer rates.

A new study looked at thousands of asthma patients in order to better understand the genetic associations of asthma.

Topical analgesics can help ease patients off of opioids, offering a ray of hope in the midst of a growing opioid addiction crisis.

New research shows overweight preschoolers have more frequent asthma symptoms, but inhalers are still effective.

Researchers in Canada say a viral therapy developed to target cancer cells can also be used to target latent HIV-infected cells.

A new study finds an endogenous metabolite, taurine, can make certain MS therapies more effective at spurring oligodendrocyte precursor cells to mature.

A new study finds that when a blood protein crosses the blood-brain barrier, it can inhibit the brain’s ability to effect remyelination.

A team of researchers has successfully created oligodendrocytes from human and rodent cells.

A new study demonstrates that opioid growth factor regulation appears to be off in patients with MS and in MS patients undergoing disease progression.

In a letter published late last month, the US Centers for Disease Control and Prevention achieves a major milestone acknowledging that antiretroviral therapy can eliminate the transmission risk.

New research suggests Ocrevus saves money over subcutaneous interferon beta 1-a in the long run, though insurers say they need more data to get a clear picture of a drug’s value.

A Seattle company is hoping its technology will help drug companies more efficiently test out the safety and efficacy of drugs that must cross the blood-brain barrier.

Six years after it was initially rejected by regulators, a new relapsing remitting multiple sclerosis drug has been approved for sale in Europe.

A deal between Biogen and a large Puerto Rican pharmacy benefits manager will tie multiple sclerosis drug payments to clinical outcomes.

A new study suggests type 2 diabetes progresses, or perhaps begins, in a manner similar to prion diseases like mad cow disease.

MS patients were significantly outscored by a control group in a series of social interaction tests.

Omitted data reveals why Lemtrada's treatment of multiple sclerosis could leave patients susceptible to secondary autoimmune conditions.

It took 5 visits to the doctor to correctly diagnose many MS patients.

Smokers found to have altered levels of MAIT than the general population.

Certain conditions are linked to multiple sclerosis disease progression.

Multiple sclerosis can lead to seizures. Researchers found the mechanism.

In multiple sclerosis, limited leg function predicts decline.

Perrigo has sold its royalty rights to an important MS drug.

Kids with asthma are four times more likely to have kidney stones.

Report underscores the need to act quickly, refer patients with eye problems.

On Tuesday, the American Medical Association's House of Delegates debated the wisdom of forming a so-called Super PAC to help influence elections. However, the idea raised a number of concerns.

The American Medical Association on Monday called the military's policy of excluding transgender service members "out of date."